Global Pneumonia Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 155289
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.

Scope of the Report:

This report focuses on the Pneumonia Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Pneumonia Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Pfizer Inc.

Glaxosmithkline Plc.

Merck & Co., Inc.

Sanofi Pasteur

Serum Institute of India Pvt. Ltd.

Johnson & Johnson

Astellas Pharma Inc.

Astrazeneca Plc.

CSL Limited

Emergent Biosolutions

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pneumococcal Conjugate Vaccine (PCV13)

Pneumococcal Polysaccharide Vaccine (PPSV23)

Market Segment by Applications, can be divided into

Pneumonia

Meningitis

Sepsis

There are 15 Chapters to deeply display the global Pneumonia Vaccine market.

Chapter 1, to describe Pneumonia Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pneumonia Vaccine, with sales, revenue, and price of Pneumonia Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumonia Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pneumonia Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pneumonia Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Pneumonia Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Pneumococcal Conjugate Vaccine (PCV13)

1.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)

1.3 Market Analysis by Applications

1.3.1 Pneumonia

1.3.2 Meningitis

1.3.3 Sepsis

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer Inc.

2.1.1 Business Overview

2.1.2 Pneumonia Vaccine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Glaxosmithkline Plc.

2.2.1 Business Overview

2.2.2 Pneumonia Vaccine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Merck & Co., Inc.

2.3.1 Business Overview

2.3.2 Pneumonia Vaccine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi Pasteur

2.4.1 Business Overview

2.4.2 Pneumonia Vaccine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Serum Institute of India Pvt. Ltd.

2.5.1 Business Overview

2.5.2 Pneumonia Vaccine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson

2.6.1 Business Overview

2.6.2 Pneumonia Vaccine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Astellas Pharma Inc.

2.7.1 Business Overview

2.7.2 Pneumonia Vaccine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Astrazeneca Plc.

2.8.1 Business Overview

2.8.2 Pneumonia Vaccine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 CSL Limited

2.9.1 Business Overview

2.9.2 Pneumonia Vaccine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Emergent Biosolutions

2.10.1 Business Overview

2.10.2 Pneumonia Vaccine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Pneumonia Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Pneumonia Vaccine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Pneumonia Vaccine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Pneumonia Vaccine Manufacturer Market Share in 2017

3.3.2 Top 6 Pneumonia Vaccine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Pneumonia Vaccine Market Analysis by Regions

4.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Pneumonia Vaccine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Pneumonia Vaccine Revenue and Market Share by Regions (2013-2018)

4.2 North America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.3 Europe Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.5 South America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5 North America Pneumonia Vaccine by Countries

5.1 North America Pneumonia Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

5.2 United States Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5.3 Canada Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5.4 Mexico Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6 Europe Pneumonia Vaccine by Countries

6.1 Europe Pneumonia Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.3 UK Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.4 France Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.5 Russia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.6 Italy Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Pneumonia Vaccine by Countries

7.1 Asia-Pacific Pneumonia Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

7.2 China Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.3 Japan Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.4 Korea Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.5 India Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8 South America Pneumonia Vaccine by Countries

8.1 South America Pneumonia Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8.3 Argentina Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8.4 Colombia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Pneumonia Vaccine by Countries

9.1 Middle East and Africa Pneumonia Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.3 UAE Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.4 Egypt Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.5 Nigeria Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.6 South Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

10 Global Pneumonia Vaccine Market Segment by Type

10.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Pneumonia Vaccine Sales and Market Share by Type (2013-2018)

10.1.2 Global Pneumonia Vaccine Revenue and Market Share by Type (2013-2018)

10.2 Pneumococcal Conjugate Vaccine (PCV13) Sales Growth and Price

10.2.1 Global Pneumococcal Conjugate Vaccine (PCV13) Sales Growth (2013-2018)

10.2.2 Global Pneumococcal Conjugate Vaccine (PCV13) Price (2013-2018)

10.3 Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth and Price

10.3.1 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth (2013-2018)

10.3.2 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Price (2013-2018)

11 Global Pneumonia Vaccine Market Segment by Application

11.1 Global Pneumonia Vaccine Sales Market Share by Application (2013-2018)

11.2 Pneumonia Sales Growth (2013-2018)

11.3 Meningitis Sales Growth (2013-2018)

11.4 Sepsis Sales Growth (2013-2018)

12 Pneumonia Vaccine Market Forecast (2018-2023)

12.1 Global Pneumonia Vaccine Sales, Revenue and Growth Rate (2018-2023)

12.2 Pneumonia Vaccine Market Forecast by Regions (2018-2023)

12.2.1 North America Pneumonia Vaccine Market Forecast (2018-2023)

12.2.2 Europe Pneumonia Vaccine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Pneumonia Vaccine Market Forecast (2018-2023)

12.2.4 South America Pneumonia Vaccine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Pneumonia Vaccine Market Forecast (2018-2023)

12.3 Pneumonia Vaccine Market Forecast by Type (2018-2023)

12.3.1 Global Pneumonia Vaccine Sales Forecast by Type (2018-2023)

12.3.2 Global Pneumonia Vaccine Market Share Forecast by Type (2018-2023)

12.4 Pneumonia Vaccine Market Forecast by Application (2018-2023)

12.4.1 Global Pneumonia Vaccine Sales Forecast by Application (2018-2023)

12.4.2 Global Pneumonia Vaccine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Pneumonia Vaccine Picture

Table Product Specifications of Pneumonia Vaccine

Figure Global Sales Market Share of Pneumonia Vaccine by Types in 2017

Table

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery